ArticleNeurosurgical review2025
Individual surgical management of trigeminal schwannomas guided by an extended classification: a consecutive series of 96 clinical cases at a single institution.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evolution of Surgical Approaches for Trigeminal Schwannomas: A Meta-Regression Analysis from Past to Present.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Trigeminal schwannoma (TS) is a rare intracranial neurinoma that affects the multicompartmental skull base. In recent decades, advancements in skull-base neurosurgical techniques and endoscopic surgery have significantly improved outcomes for TS patients. In this study, we present our experience with surgical resection of TS using a further classification system. We conducted a retrospective analysis of the clinical, surgical, and follow-up data of 96 patients diagnosed with TS at our institution between March 2012 and June 2022. The tumors were classified based on the MPE classification, with Type M further divided into M1 and M2 subtypes according to the origin of the tumor and the patterns of cavernous sinus (CS) invasion. Type MP tumors were divided into M1P and M2P subtypes based on whether the tumors in the middle cranial fossa extended into the anterior CS. Optimal surgical approaches were proposed for each subtype. The outcomes of the case series were collected and analyzed. Based on the further MPE classification, 32 tumors were classified as Type M2P, 21 as Type M1P, 12 as Type ME, 8 as Type P, 8 as Type M1, 8 as Type MPE, and 7 as Type M2. Gross total resection (GTR) was achieved in 88 patients, while five patients underwent subtotal resection (STR), and three patients received partial resection (PR). No deaths occurred during the perioperative period. The extended MPE classification provides specific insights into the features of TS involving the middle fossa, enabling more individualized and tailored treatment strategies, as well as appropriate approach selection. The combination of microsurgery, endoscopic surgery, and stereotactic radiotherapy can lead to satisfactory outcomes in managing complex TS, achieving high rates of GTR while minimizing complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.